GSI 250 (Viread 250 mg)
Generic Name: tenofovir
This pill with imprint "GSI 250" is White, Capsule-shape and has been identified as Viread 250 mg. It is supplied by Gilead Sciences, Inc..
Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Viread
- Generic Name:
- tenofovir
- Imprint:
- GSI 250
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gilead Sciences, Inc.
- Inactive Ingredients:
- corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
triacetin
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
More about Viread (tenofovir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 8 Reviews – Add your own review/rating
- Generic Availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Viread
- Viread (Tenofovir Disoproxil Fumarate Oral Powder)
- Viread (Tenofovir Disoproxil Fumarate Tablets)
- Viread (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
